BREAKING NEWS: FORZA™ now in Phase 2 Clinical Trial for Progressive Multiple Sclerosis

As a boutique biotech company, we at 9D Biotech aim to advance high-impact R&D at the nexus of human health and plant biotechnology by sponsoring cutting edge research, establishing collaborations with leading international research institutions, and growing our interdisciplinary network of scientists and professionals with the goal of solving some of the greatest challenges facing humanity today. 

Our portfolio holds a selection of game-changing biotech projects at various stages of development, among which are the world's first and only Osmotin-rich kiwi and olive plants - our leading, market-ready technology and the source of our revolutionary product FORZA™.